Cargando…

Genomic Assays in Node Positive Breast Cancer Patients: A Review

In recent years, developments in breast cancer have allowed yet another realization of individualized medicine in the field of oncology. One of these advances is genomic assays, which are considered elements of standard clinical practice in the management of breast cancer. These assays are widely us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bou Zerdan, Maroun, Ibrahim, Maryam, El Nakib, Clara, Hajjar, Rayan, Assi, Hazem I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921691/ https://www.ncbi.nlm.nih.gov/pubmed/33665165 http://dx.doi.org/10.3389/fonc.2020.609100

Ejemplares similares

Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Glioblastoma multiforme metastasizing to the skin, a case report and literature review
por: Nakib, Clara El, et al.
Publicado: (2021)

Olaratumab’s failure in soft tissue sarcoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022)

Oligodendroglioma: A Review of Management and Pathways
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients
por: Assi, Hazem I., et al.
Publicado: (2021)

Latest updates on cellular and molecular biomarkers of gliomas
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Outcomes of Patients with Malignancy Admitted to the Intensive Care Units: A Prospective Study
por: Assi, Hazem I., et al.
Publicado: (2021)

Mechanisms of Immunotoxicity: Stressors and Evaluators
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon
por: Atoui, Ali, et al.
Publicado: (2022)

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
por: Fahed, Gracia, et al.
Publicado: (2022)

Carbapenemase Inhibitors: Updates on Developments in 2021
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
por: Moubarak, Simon, et al.
Publicado: (2022)

Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Descriptive epidemiology of soft tissue and bone sarcomas in Lebanon
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

A Survey on the Knowledge, Attitudes, and Practices of Lebanese Physicians Regarding Air Pollution
por: Assi, Hazem I., et al.
Publicado: (2022)

Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials
por: El Sayed, Rola, et al.
Publicado: (2019)

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer
por: Al Mahmasani, Layal, et al.
Publicado: (2023)

Insights of Medical Students and Graduates Toward Electronic Learning During the COVID-19 Pandemic in Lebanon: A National Cross-Sectional Study
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

Emerging genetic biomarkers in lung adenocarcinoma
por: Barbar, Jawad, et al.
Publicado: (2022)

Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature
por: Zerdan, Maroun Bou, et al.
Publicado: (2021)

Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022)

Idiopathic Granulomatous Mastitis Presenting as a Breast Pseudotumor: Case Reports with Review of the Literature
por: Halim, Nour Abdul, et al.
Publicado: (2018)

Fertility in multiple recurrent bilateral ovarian teratomas: A case report
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

The effects of ECE on the benefits of PMRT for breast cancer patients with positive axillary nodes
por: Geng, Wenwen, et al.
Publicado: (2013)

Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota
por: Bouferraa, Youssef, et al.
Publicado: (2023)

Recent Advances in the Treatment and Supportive Care of POEMS Syndrome
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Controversial Indications for Sentinel Lymph Node Biopsy in Breast Cancer Patients
por: Assi, Hazem, et al.
Publicado: (2015)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
por: Garcia-Tejedor, Amparo, et al.
Publicado: (2023)

Clinical Utility of Genomic Assay in Node-Positive Early-Stage Breast Cancer
por: Pauls, Mehrnoosh, et al.
Publicado: (2022)

Candidates of Genomic Tests in HR+/HER2- Breast Cancer Patients With 1-2 Positive Sentinel Lymph Node Without Axillary Lymph Node Dissection: Analysis From Multicentric Cohorts
por: Bi, Zhao, et al.
Publicado: (2021)

Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients
por: Li, Zhuoxuan, et al.
Publicado: (2022)

Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2kooi28q3q6lf8shqqulm0ls8